融合途径:在间歇性肺部疾病中对肺高血压的审查
Alexandra Lawrence1, Katherine Jane Myall1,2, Bhashkar Mukherjee1,3
1Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
Life (Basel, Switzerland)
|September 28, 2024
概括
间歇性肺病 (PH-ILD) 中的肺高血压是常见的,并且与不良结果有关. 研究表明纤维化肺病和PH之间有共同的途径,提供了新的治疗点.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 病理学 病理学 病理学
背景情况:
- 肺高血压 (PH) 经常复杂化间歇性肺病 (ILD),特别是异常性肺纤维化 (IPF),影响患者的发病率和死亡率.
- 病理机制包括缺氧肺血管收缩和血管重塑,有新出现的证据表明ILD和PH之间的共享病原体.
研究的目的:
- 审查目前在ILD (PH-ILD) 中PH的临床试验和治疗策略.
- 探索纤维化ILD和PH病原发生的相互联系.
- 讨论PH-ILD的准确表型和管理方法.
主要方法:
- 对PH-ILD疗法的关键临床试验的审查.
- 分析最近关于PH-ILD和潜在纤维化过程治疗的研究.
- 在PH-ILD管理中讨论表型化策略.
主要成果:
- 最近的治疗研究表明,治疗PH-ILD和纤维性肺病是有希望的.
- "肺血管"表型在治疗PH-ILD方面被证明是有价值的.
- 证据支持ILD病原和PH之间的相互作用,涉及肺内皮.
结论:
- 纤维性ILD和PH具有密切相互联系的病原体.
- 了解这种联系对于改善未来对PH-ILD的治疗方法至关重要.
- 准确的表型确定对于有效管理PH-ILD至关重要.
更多相关视频
相关概念视频
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Pulmonary Hypertension: Classification and Pathogenesis
906
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
906
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
Pulmonary Edema II: Pathophysiology
39
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
39
Portal Hypertension
50
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50


